Figure 1. Study schema.
Ara-C = cytarabine; BEAM = carmustine [BCNU]/etoposide/cytarabine/melphalan; CBV = carmustine [BCNU], cyclophosphamide, etoposide; Cy, cyclophosphamide; HCVAD = ; HyperCVAD (hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone, alternating with high dose cytarabine and methotrexate) MTX, = methotrexate; PR = partial response; R = rituximab; TBI = total body irradiation; VP16 = etoposide.